Improved Treatment Efficacy of Antiangiogenic Therapy when Combined with Picornavirus Vaccination in the GL261 Glioma Model
出版年份 2015 全文链接
标题
Improved Treatment Efficacy of Antiangiogenic Therapy when Combined with Picornavirus Vaccination in the GL261 Glioma Model
作者
关键词
Glioma, Combination therapy, Antiangiogenic, Tumor invasiveness, Immunotherapy
出版物
Neurotherapeutics
Volume 13, Issue 1, Pages 226-236
出版商
Springer Nature
发表日期
2015-12-01
DOI
10.1007/s13311-015-0407-1
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Effective Treatment of Established GL261 Murine Gliomas through Picornavirus Vaccination-Enhanced Tumor Antigen-Specific CD8+ T Cell Responses
- (2015) Danielle N. Renner et al. PLoS One
- Autologous T-cell Therapy for Cytomegalovirus as a Consolidative Treatment for Recurrent Glioblastoma
- (2014) A. Schuessler et al. CANCER RESEARCH
- A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
- (2014) Mark R. Gilbert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
- (2014) Olivier L. Chinot et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma
- (2014) F. S. Hodi et al. Cancer Immunology Research
- Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme
- (2013) Yasushi Soda et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- The Epitope Integration Site for Vaccine Antigens Determines Virus Control While Maintaining Efficacy in an Engineered Cancer Vaccine
- (2013) Kevin D Pavelko et al. MOLECULAR THERAPY
- The immunomodulatory effects of bevacizumab on systemic immunity in patients with metastatic melanoma
- (2013) Aaron S. Mansfield et al. OncoImmunology
- Differentiation between Brain Glioblastoma Multiforme and Solitary Metastasis: Qualitative and Quantitative Analysis Based on Routine MR Imaging
- (2012) X.Z. Chen et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
- (2012) Nicholas Papadopoulos et al. ANGIOGENESIS
- Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease
- (2012) Azeb Tadesse Argaw et al. JOURNAL OF CLINICAL INVESTIGATION
- CD8 T Cell-Initiated Blood-Brain Barrier Disruption Is Independent of Neutrophil Support
- (2012) H. L. Johnson et al. JOURNAL OF IMMUNOLOGY
- Vaccine Injection Site Matters: Qualitative and Quantitative Defects in CD8 T Cells Primed as a Function of Proximity to the Tumor in a Murine Glioma Model
- (2012) J. R. Ohlfest et al. JOURNAL OF IMMUNOLOGY
- Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy
- (2012) Y. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A critical role for regulatory T cells in driving cytokine profiles of Th17 cells and their modulation of glioma microenvironment
- (2011) Gabriele Cantini et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Phase II Study of Aflibercept in Recurrent Malignant Glioma: A North American Brain Tumor Consortium Study
- (2011) John F. de Groot et al. JOURNAL OF CLINICAL ONCOLOGY
- Topical Imiquimod has Therapeutic and Immunomodulatory Effects Against Intracranial Tumors
- (2011) Zhengming Xiong et al. JOURNAL OF IMMUNOTHERAPY
- A clinical trial of bevacizumab, temozolomide, and radiation for newly diagnosed glioblastoma
- (2011) Ashwatha Narayana et al. JOURNAL OF NEUROSURGERY
- Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice
- (2011) J. F. de Groot et al. NEURO-ONCOLOGY
- A phase II trial of single-agent bevacizumab in patients with recurrent anaplastic glioma
- (2011) T. N. Kreisl et al. NEURO-ONCOLOGY
- Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma
- (2011) Olivier Keunen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effects of bevacizumab plus irinotecan on response and survival in patients with recurrent malignant glioma: a systematic review and survival-gain analysis
- (2010) Tao Xu et al. BMC CANCER
- Experimental immunotherapy for malignant glioma: lessons from two decades of research in the GL261 model
- (2010) Wim Maes et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Heterogeneous Blood-Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer
- (2010) P. R. Lockman et al. CLINICAL CANCER RESEARCH
- Gene Expression Profile Correlates with T-Cell Infiltration and Relative Survival in Glioblastoma Patients Vaccinated with Dendritic Cell Immunotherapy
- (2010) Robert M. Prins et al. CLINICAL CANCER RESEARCH
- Dynamic magnetic resonance imaging assessment of vascular targeting agent effects in rat intracerebral tumor models
- (2010) L. L. Muldoon et al. NEURO-ONCOLOGY
- Infiltrating CTLs in Human Glioblastoma Establish Immunological Synapses with Tumorigenic Cells
- (2009) Carlos Barcia et al. AMERICAN JOURNAL OF PATHOLOGY
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
- (2009) Marta Pàez-Ribes et al. CANCER CELL
- Systemic Inhibition of Transforming Growth Factor- in Glioma-Bearing Mice Improves the Therapeutic Efficacy of Glioma-Associated Antigen Peptide Vaccines
- (2009) R. Ueda et al. CLINICAL CANCER RESEARCH
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Study of Intravenous Vascular Endothelial Growth Factor Trap, Aflibercept, in Patients With Advanced Solid Tumors
- (2009) A. Craig Lockhart et al. JOURNAL OF CLINICAL ONCOLOGY
- CD8 T Cell-Initiated Vascular Endothelial Growth Factor Expression Promotes Central Nervous System Vascular Permeability under Neuroinflammatory Conditions
- (2009) G. L. Suidan et al. JOURNAL OF IMMUNOLOGY
- Flow cytometry and in vitro analysis of human glioma–associated macrophages
- (2009) Ian F. Parney et al. JOURNAL OF NEUROSURGERY
- FDA Drug Approval Summary: Bevacizumab (Avastin(R)) as Treatment of Recurrent Glioblastoma Multiforme
- (2009) M. H. Cohen et al. ONCOLOGIST
- HIF1α Induces the Recruitment of Bone Marrow-Derived Vascular Modulatory Cells to Regulate Tumor Angiogenesis and Invasion
- (2008) Rose Du et al. CANCER CELL
- Vaccination Elicits Correlated Immune and Clinical Responses in Glioblastoma Multiforme Patients
- (2008) C. J. Wheeler et al. CANCER RESEARCH
- Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan
- (2008) R. M. Zuniga et al. JOURNAL OF NEURO-ONCOLOGY
- An exploratory survival analysis of anti-angiogenic therapy for recurrent malignant glioma
- (2008) Andrew D. Norden et al. JOURNAL OF NEURO-ONCOLOGY
- VEGF Trap induces antiglioma effect at different stages of disease
- (2008) Candelaria Gomez-Manzano et al. NEURO-ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started